The Effect of Adding an IPACK Block to the Adductor Canal Block on Total Knee Arthroplasty Surgery
Launched by AYDIN ADNAN MENDERES UNIVERSITY · Sep 5, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new approach to help manage pain after total knee arthroplasty (TKA), which is a common surgery for knee replacement. Many patients experience significant pain after this procedure, which can slow down their recovery and lead to complications. The study is looking at whether adding a specific type of nerve block (the IPACK block) to an existing pain management technique (the adductor canal block) can improve pain relief, help patients move around more quickly, and ultimately lead to a faster recovery.
To participate in this study, you need to be at least 18 years old and scheduled for elective total knee surgery. You will also need to be in good health overall, as determined by your doctor. The trial is open to everyone, regardless of gender. Participants will receive spinal anesthesia, and those who meet the criteria will be informed about the trial's details and asked to provide consent before joining. If you're interested, the study team will guide you through what to expect during the trial process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with written informed consent
- • 2. Patients over 18 years old undergoing elective total knee arthroplasty surgery
- • 3. Patients with ASA I-II-III
- • 4. Patients receiving spinal anesthesia
- Exclusion Criteria:
- • 1. Revision knee arthroplasty and bilateral total knee arthroplasty
- • 2. Liver or kidney failure
- • 3. Patients under 18 years old
- • 4. Patients receiving general anesthesia
- • 5. Allergy or intolerance to study medications
- • 6. Body mass index (BMI) \> 40 kg/m²
- • 7. Chronic use of gabapentin/pregabalin (regular use for more than 3 months)
- • 8. Chronic opioid use (opioid use for more than 3 months or daily oral morphine equivalent \> 5 mg/day for 1 month)
- • 9. Patients with ASA IV and those undergoing emergency surgery
About Aydin Adnan Menderes University
Aydin Adnan Menderes University is a leading academic institution based in Turkey, renowned for its commitment to advancing medical research and education. The university actively sponsors clinical trials that aim to explore innovative therapeutic approaches and enhance patient care. With a multidisciplinary team of experts, state-of-the-art facilities, and a dedication to ethical research practices, Aydin Adnan Menderes University fosters a collaborative environment that supports the development of groundbreaking medical solutions, ultimately aiming to improve health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aydın, , Turkey
Patients applied
Trial Officials
MURAT DEMİRCİOGLU
Study Chair
muratdemircioglu01@gmail.com
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported